Cargando…

Severe hypertransaminasemia during mild SARS‐CoV‐2 infection: A pediatric case report and literature review

INTRODUCTION: Liver injury during SARS‐CoV‐2 infection has a multifactorial pathogenesis and it is frequent in pediatric cases. CASE PRESENTATION: We report a case with severe hypertransaminasemia associated with mild SARS‐CoV‐2 infection. CONCLUSION: This highlights the potential need of hepatic fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palpacelli, Alessandra, Martelli, Gaia, Lattanzi, Bianca, Volpini, Alessandro, Cazzato, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662248/ https://www.ncbi.nlm.nih.gov/pubmed/34909233 http://dx.doi.org/10.1002/ped4.12300

Ejemplares similares

Mild Hypertransaminasemia in Primary Care
por: Al-Busafi, Said A., et al.
Publicado: (2013)

Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis
por: Zippi, Maddalena, et al.
Publicado: (2020)

The etiology of hypertransaminasemia in Turkish children
por: Serdaroglu, Filiz, et al.
Publicado: (2016)

From hypertransaminasemia to mucopolysaccharidosis IIIA
por: Krawiec, Paulina, et al.
Publicado: (2014)

Hypertransaminasemia and fatal lung disease: a case report
por: Santamaria, Francesca, et al.
Publicado: (2013)

Hypertransaminasemia and hypophosphoremia in an adolescent with anorexia nervosa: an event to watch for
por: Marchili, Maria Rosaria, et al.
Publicado: (2016)

The Effects of Gluten-Free Diet on Hypertransaminasemia in Patients with Celiac Disease
por: Moghaddam, Mostafa Alavi, et al.
Publicado: (2013)

Incidental hypertransaminasemia in children—a stepwise approach in primary care
por: Costa, Joana Meneses, et al.
Publicado: (2023)

Celiac Disease in Conjunction with Hereditary Fructose Intolerance as a Rare Cause of Liver Steatosis with Mild Hypertransaminasemia—A Case Report
por: Bobrus-Chociej, Anna, et al.
Publicado: (2021)

TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

The effect of Helicobacter pylori eradication on liver enzymes in patients referring with unexplained hypertransaminasemia
por: Salehi, Hassan, et al.
Publicado: (2014)

Early Hypertransaminasemia after Kidney Transplantation: Significance and Evolution According to Donor Type
por: Solà-Porta, Eulàlia, et al.
Publicado: (2021)

Something Is Changing in Viral Infant Bronchiolitis Approach
por: Bottau, Paolo, et al.
Publicado: (2022)

c.761C>T Mutation Linked Hyper IgM Syndrome Presenting with Hypertransaminasemia and Arthritis
por: Celiksoy, Mehmet Halil, et al.
Publicado: (2014)

Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Villani, Rosanna, et al.
Publicado: (2019)

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia
por: Fuentes-Antrás, Jesús, et al.
Publicado: (2020)

PReS-FINAL-1005: Hypertransaminasemia in systemic juvenile idiopathic arthritis during anti-interleukin 1 treatment
por: Gonzalez Fernandez, MI, et al.
Publicado: (2013)

Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance
por: Paolella, Giulia, et al.
Publicado: (2012)

Neuroradiological Features of Mild and Severe SARS-CoV-2 Infection
por: Pan, Simon, et al.
Publicado: (2020)

Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
por: Alonso‐Peña, Marta, et al.
Publicado: (2022)

Different mutations in SARS-CoV-2 associate with severe and mild outcome
por: Nagy, Ádám, et al.
Publicado: (2021)

Cutaneous Manifestations of SARS-CoV-2, Cutaneous Adverse Reactions to Vaccines Anti-SARS-CoV-2 and Clinical/Dermoscopical Findings: Where We Are and Where We Will Go
por: Cazzato, Gerardo
Publicado: (2023)

Ischemic Priapism During Severe SARS-CoV-2 Infection: A Case Report and Literature Review
por: De Rose, Aldo Franco, et al.
Publicado: (2022)

Characterization of the antibody response to SARS‐CoV‐2 in a mildly affected pediatric population
por: Kopanja, Sonja, et al.
Publicado: (2022)

Severity predictors in pediatric SARS-CoV-2 and MIS-C
por: Zachariah, Philip
Publicado: (2021)

Peripheral nervous system involvement in SARS-CoV-2 infection: a review of the current pediatric literature
por: Perilli, Lorenzo, et al.
Publicado: (2023)

Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases
por: Carsetti, Rita, et al.
Publicado: (2020)

Durable SARS-CoV-2 B cell immunity after mild or severe disease
por: Ogega, Clinton O., et al.
Publicado: (2020)

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
por: Zhang, Fan, et al.
Publicado: (2020)

Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
por: Tahmasebi, Safa, et al.
Publicado: (2021)

Temporal patterns of nasal symptoms in patients with mild severity SARS-CoV-2 infection
por: Raad, Richard A., et al.
Publicado: (2021)

Role Of Immune-Nutrition In Sars-Cov 2 Patients From A Mild Intensity Clinic
por: Scarpellini, E., et al.
Publicado: (2023)

Mycobacterium chimaera: a report of 2 new cases and literature review
por: Natanti, Alice, et al.
Publicado: (2021)

Severe pediatric acute encephalopathy syndromes related to SARS-CoV-2
por: Sakuma, Hiroshi, et al.
Publicado: (2023)

SARS-CoV-2 infection in pediatric population
por: Manti, Sara, et al.
Publicado: (2020)

Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
por: Gervasi, Salvatore Francesco, et al.
Publicado: (2021)

SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
por: Anderson, Elizabeth M., et al.
Publicado: (2020)

Correction to: Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
por: Zhang, Fan, et al.
Publicado: (2021)

Brain disorders: Impact of mild SARS-CoV-2 may shrink several parts of the brain
por: Kumar, Puranam Revanth, et al.
Publicado: (2023)

Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease
por: Okendo, Javan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03n29cs212f4fg06m69f5mvdu7